Regeneron Pharmaceuticals, Inc. (LON:0R2M)

Regeneron Pharmaceuticals Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 9, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	46,043	61,217	73,329	63,953	48,764	37,347
Market Cap Growth	-35.85%	-16.52%	14.66%	31.15%	30.57%	20.50%
Enterprise Value	34,748	48,770	63,131	55,414	42,324	34,998
Last Close Price	433.38	562.97	687.86	590.61	469.81	356.36
PE Ratio	13.22	17.37	23.63	17.76	8.18	14.51
PS Ratio	4.22	5.40	7.12	6.33	4.11	6.00
PB Ratio	2.02	2.61	3.60	3.40	3.52	4.63
P/TBV Ratio	2.11	2.72	3.75	3.54	3.52	4.63
P/FCF Ratio	-	20.91	24.10	17.42	10.11	25.45
P/OCF Ratio	-	17.34	20.33	15.37	9.32	19.48
EV/Sales Ratio	3.26	4.30	6.13	5.49	3.57	5.62
EV/EBITDA Ratio	10.18	13.19	17.28	12.51	6.18	12.25
EV/EBIT Ratio	11.55	14.73	19.00	13.37	6.37	13.04
EV/FCF Ratio	14.47	16.66	20.75	15.09	8.78	23.85
Debt / Equity Ratio	0.09	0.10	0.11	0.12	0.14	0.25
Debt / EBITDA Ratio	0.60	0.63	0.60	0.52	0.29	0.69
Debt / FCF Ratio	0.87	0.80	0.72	0.63	0.41	1.35
Asset Turnover	0.39	0.40	0.42	0.45	0.76	0.53
Inventory Turnover	2.44	2.51	2.51	2.37	2.74	2.26
Quick Ratio	3.90	3.86	4.82	4.16	2.98	2.86
Current Ratio	4.93	4.73	5.69	5.06	3.56	3.63
Return on Equity (ROE)	15.96%	15.95%	16.26%	20.94%	54.21%	31.77%
Return on Assets (ROA)	6.91%	7.31%	8.49%	11.42%	26.39%	14.33%
Return on Capital (ROIC)	8.04%	8.49%	9.76%	13.31%	31.95%	17.95%
Return on Capital Employed (ROCE)	11.70%	12.30%	14.30%	19.20%	41.80%	25.30%
Earnings Yield	7.56%	5.76%	4.23%	5.63%	12.23%	6.89%
FCF Yield	5.21%	4.78%	4.15%	5.74%	9.89%	3.93%
Buyback Yield / Dilution	-0.13%	-1.23%	-0.18%	-1.16%	2.52%	-0.44%

Updated Feb 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.